# ZBTB7A

## Overview
ZBTB7A is a gene that encodes the zinc finger and BTB domain-containing protein 7A, also known as LRF or Pokemon. This protein is a transcription factor characterized by its BTB/POZ domain and multiple C2H2-type zinc finger motifs, which facilitate protein-protein interactions and DNA binding, respectively (Singh2021Role; Constantinou2019The). ZBTB7A plays a crucial role in various cellular processes, including hematopoietic differentiation, erythropoiesis, and the regulation of glycolytic metabolism, acting as a tumor suppressor by repressing glycolysis (Liu2014ZBTB7A; Redondo2020ZBTB7A). The protein's interactions with corepressor complexes and transcription factors underscore its importance in gene expression regulation and cellular function (Ramos2018Zbtb7a; Singh2021Role). ZBTB7A's involvement in cancer biology is complex, as it can function as both an oncogene and a tumor suppressor, depending on the context, making it a potential target for therapeutic interventions (Geng2020ZBTB7A; Apostolopoulou2007Gene).

## Structure
The ZBTB7A protein, also known as LRF or Pokemon, is characterized by its BTB/POZ domain and multiple C2H2-type zinc finger motifs. The BTB domain, located at the N-terminus, facilitates protein-protein interactions and allows for the formation of homo- or hetero-dimers, which is crucial for its function as a transcription factor (Ramos2018Zbtb7a; Constantinou2019The). The zinc finger domains, particularly the four C-terminal Krüppel-type zinc fingers, provide sequence-specific DNA-binding capacity, enabling ZBTB7A to interact with genomic promoters and enhancers (Singh2021Role; Constantinou2019The).

The protein is highly conserved across species, with 584 amino acids in most primates and 569 in mice, indicating its evolutionary importance (Chondrou2020LRFZBTB7A). The conservation of the BTB and zinc finger domains across species underscores their critical role in the protein's function (Chondrou2020LRFZBTB7A). ZBTB7A is involved in various cellular processes, including transcription co-repressor activity and modulation of other transcription factors' activities (Constantinou2019The).

Post-translational modifications, such as phosphorylation, may regulate the activity of ZBTB7A, although specific details are not provided in the context. Splice variants can result in different isoforms, potentially leading to distinct functional roles (Constantinou2019The).

## Function
ZBTB7A, also known as LRF, is a transcription factor that plays a critical role in various cellular processes in healthy human cells. It is involved in hematopoietic differentiation, influencing the fate of myeloid cells by promoting granulopoiesis and blocking monocytic differentiation. This regulation is essential for maintaining the balance of myeloid cell differentiation and preventing clonal expansion in hematopoietic stem and progenitor cells (Redondo2020ZBTB7A). ZBTB7A also plays a role in erythropoiesis by repressing Bim-mediated apoptosis and interacting with the erythroid transcription factor GATA1 (Redondo2020ZBTB7Aa).

In addition to its role in differentiation, ZBTB7A acts as a tumor suppressor by repressing glycolysis. It regulates glycolytic metabolism independently of the transcription factors HIF-1a and MYC, thereby preventing the Warburg effect, which is characterized by elevated aerobic glycolysis in cancer cells (Liu2014ZBTB7A). ZBTB7A is also involved in regulating promoter accessibility, acting as a transducer for transcription factors to modulate gene expression, which is crucial for maintaining normal cellular functions (Ramos2018Zbtb7a). This multifaceted role highlights ZBTB7A's importance in both normal physiological processes and disease prevention.

## Clinical Significance
The ZBTB7A gene, also known as LRF, plays a significant role in various cancers, acting as both an oncogene and a tumor suppressor depending on the context. In uterine corpus endometrial carcinoma (UCEC), ZBTB7A expression is notably downregulated, correlating with poor prognosis and lower overall survival rates (Geng2020ZBTB7A). In contrast, ZBTB7A is overexpressed in non-small cell lung cancer (NSCLC), where it is associated with increased tumor size and proliferation (Apostolopoulou2007Gene). 

In breast cancer, high ZBTB7A expression is linked to increased cell proliferation and resistance to apoptosis, while its silencing leads to increased apoptosis (Singh2021Role). In liver cancer, ZBTB7A promotes invasiveness and metastasis by regulating NF-κB signaling and the PI3K/AKT pathway (Singh2021Role). 

ZBTB7A mutations are also implicated in acute myeloid leukemia (AML), particularly with the t(8;21) translocation, where they disrupt myeloid differentiation and increase glycolysis, making leukemic cells more sensitive to metabolic inhibitors (Redondo2020ZBTB7A). These findings highlight the gene's complex role in cancer biology and its potential as a therapeutic target.

## Interactions
ZBTB7A, also known as LRF, is a transcription factor that engages in various interactions with proteins and nucleic acids, influencing gene expression and cellular processes. It interacts with corepressor complexes such as NCoR, SMRT, and mSin3A, which are associated with histone deacetylases (HDACs) through its BTB domain, playing a role in transcriptional repression (Singh2021Role). ZBTB7A also binds to specific DNA sequences, regulating target gene transcription and promoter accessibility, often acting as a transducer for transcription factors like NF-κB (Ramos2018Zbtb7a).

In cancer, ZBTB7A interacts with various proteins and pathways. It binds to the TA3 region of the p65 subunit of NF-κB, facilitating transcriptional activation of genes in response to TNF-α stimulation (Ramos2018Zbtb7a). ZBTB7A also interacts with proteins involved in cell cycle regulation, such as p53, p21, and p27, and modulates pathways like PI3K/AKT and RAS/RAF/MEK/ERK, affecting cell proliferation and survival (Constantinou2019The). In addition, ZBTB7A forms complexes with proteins like MEF2D and MT1-MMP, contributing to cancer invasiveness and metastasis (Constantinou2019The). These interactions highlight ZBTB7A's multifaceted role in cellular regulation and cancer progression.


## References


[1. (Geng2020ZBTB7A) Rong Geng, Yuhua Zheng, Donghua zhou, Qingdong Li, Ruiman Li, and Xiaoling Guo. Zbtb7a, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments. Cancer Cell International, November 2020. URL: http://dx.doi.org/10.1186/s12935-020-01600-5, doi:10.1186/s12935-020-01600-5. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-020-01600-5)

[2. (Apostolopoulou2007Gene) K Apostolopoulou, IS Pateras, K Evangelou, PK Tsantoulis, M Liontos, C Kittas, DG Tiniakos, A Kotsinas, C Cordon‐Cardo, and VG Gorgoulis. Gene amplification is a relatively frequent event leading to zbtb7a (pokemon) overexpression in non‐small cell lung cancer. The Journal of Pathology, 213(3):294–302, September 2007. URL: http://dx.doi.org/10.1002/path.2222, doi:10.1002/path.2222. This article has 50 citations.](https://doi.org/10.1002/path.2222)

[3. (Ramos2018Zbtb7a) José Miguel Ramos Pittol, Agata Oruba, Gerhard Mittler, Simona Saccani, and Dominic van Essen. Zbtb7a is a transducer for the control of promoter accessibility by nf-kappa b and multiple other transcription factors. PLOS Biology, 16(5):e2004526, May 2018. URL: http://dx.doi.org/10.1371/journal.pbio.2004526, doi:10.1371/journal.pbio.2004526. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.2004526)

[4. (Chondrou2020LRFZBTB7A) Vasiliki Chondrou, Georgios S. Markopoulos, George P. Patrinos, Alexandra Kouraklis-Symeonidis, Argiris Symeonidis, Adamantia Papachatzopoulou, and Argyro Sgourou. Lrf/zbtb7a conservation accentuates its potential as a therapeutic target for the hematopoietic disorders. Gene, 760:145020, November 2020. URL: http://dx.doi.org/10.1016/j.gene.2020.145020, doi:10.1016/j.gene.2020.145020. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2020.145020)

[5. (Redondo2020ZBTB7A) Enric Redondo Monte, Anja Wilding, Georg Leubolt, Paul Kerbs, Johannes W. Bagnoli, Luise Hartmann, Wolfgang Hiddemann, Linping Chen-Wichmann, Stefan Krebs, Helmut Blum, Monica Cusan, Binje Vick, Irmela Jeremias, Wolfgang Enard, Sebastian Theurich, Christian Wichmann, and Philipp A. Greif. Zbtb7a prevents runx1-runx1t1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Oncogene, 39(15):3195–3205, March 2020. URL: http://dx.doi.org/10.1038/s41388-020-1209-4, doi:10.1038/s41388-020-1209-4. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-020-1209-4)

[6. (Redondo2020ZBTB7Aa) Enric Redondo Monte, Paul Kerbs, and Philipp A. Greif. Zbtb7a links tumor metabolism to myeloid differentiation. Experimental Hematology, 87:20-24.e1, July 2020. URL: http://dx.doi.org/10.1016/j.exphem.2020.05.010, doi:10.1016/j.exphem.2020.05.010. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exphem.2020.05.010)

[7. (Constantinou2019The) Caterina Constantinou, Magda Spella, Vasiliki Chondrou, George P. Patrinos, Adamantia Papachatzopoulou, and Argyro Sgourou. The multi-faceted functioning portrait of lrf/zbtb7a. Human Genomics, December 2019. URL: http://dx.doi.org/10.1186/s40246-019-0252-0, doi:10.1186/s40246-019-0252-0. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-019-0252-0)

[8. (Liu2014ZBTB7A) Xue-Song Liu, Jenna E. Haines, Elie K. Mehanna, Matthew D. Genet, Issam Ben-Sahra, John M. Asara, Brendan D. Manning, and Zhi-Min Yuan. Zbtb7a acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes &amp; Development, 28(17):1917–1928, September 2014. URL: http://dx.doi.org/10.1101/gad.245910.114, doi:10.1101/gad.245910.114. This article has 89 citations.](https://doi.org/10.1101/gad.245910.114)

[9. (Singh2021Role) Atul Kumar Singh, Shiv Verma, Prem Prakash Kushwaha, Kumari Sunita Prajapati, Mohd Shuaib, Shashank Kumar, and Sanjay Gupta. Role of zbtb7a zinc finger in tumorigenesis and metastasis. Molecular Biology Reports, 48(5):4703–4719, May 2021. URL: http://dx.doi.org/10.1007/s11033-021-06405-x, doi:10.1007/s11033-021-06405-x. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-021-06405-x)